Informations générales (source: ClinicalTrials.gov)
Respiratory Rehabilitation at Home vs in the Center for Patients With Chronic Obstructive Pulmonary Disease: Efficacy, Preferences and Costs (REHABDO)
Interventional
N/A
University Hospital, Lille (Voir sur ClinicalTrials)
octobre 2018
janvier 2022
29 juin 2024
The aim of this clinical trial is to establish the non-inferiority of home-based
respiratory rehabilitation compared to respiratory rehabilitation in center in terms of
exercise tolerance as evaluated by the 6 minutes Stepper test..
This trial will also 1°) evaluate the Medico-economic aspects of the home-based
Respiratory rehabilitation versus respiratory Rehabilitation in center; 2°) analyse the
patient preferences between home-based respiratory rehabilitation and respiratory
rehabilitation in center and 3°) Compare home-based respiratory rehabilitation vs
respiratory rehabilitation in center in terms of dyspnea, quality of life, anxiety and
depression.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre hospitalier de béthune - Béthune - France | Contact (sur clinicalTrials) | ||||
| CH de Béthune - Béthune - France | Contact (sur clinicalTrials) | ||||
| CH de Loos - Loos - France | Contact (sur clinicalTrials) | ||||
| CH de Wattrelos - Wattrelos - France | Contact (sur clinicalTrials) | ||||
| CH Victor Provot, Roubaix - Roubaix - France | Contact (sur clinicalTrials) | ||||
| Hôpital Calmette, CHU - Lille - France | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CH de Tourcoing - Tourcoing - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:According to HAS recommendations, SPLF, ERS / ATS (3) (18) (19) can be
included any patient, over 18 years old, with stage II - III - IV COPD presenting
disabling dyspnoea in activities of daily living, and / or in the course of acute
exacerbation of COPD (EABPCO), with no other respiratory pathology diagnosed.
included any patient, over 18 years old, with stage II - III - IV COPD presenting
disabling dyspnoea in activities of daily living, and / or in the course of acute
exacerbation of COPD (EABPCO), with no other respiratory pathology diagnosed.
According to the recommendations, HAS, SPLF, ERS / ATS will not be included any patient
having :
- co-morbidities including unstabilized cardiovascular disease,
- significant cognitive disorders: patients with a history of pathologies
neurodegenerative with loss of mental faculties (example: Alzheimer)
- psychiatric disorders: patients with impaired judgment and perception
- neurological or orthopedic disorders that do not allow the realization of physical
activities
Also, will not be included, the patient (s):
- waiting for lung transplantation,
- pregnant or nursing,
- in an emergency situation
- unable to receive enlightened information,
- unable to participate in the entire study,
- not covered by the social security scheme,
- refusing to sign the consent,